COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking
-
- STATUS
- Recruiting
-
- participants needed
- 500
-
- sponsor
- Universitätsklinikum Hamburg-Eppendorf
Summary
The COVIDHELP study will prospectively evaluate the yet unknown clinical course of the COVID-19 infection in cancer patients and document the impact of potential infrastructural limitations on cancer care of COVID-19 positive patients. All patients consenting will provide peripheral blood samples for prospective biobanking with the aim of investigating immune response and immunity against COVID-19.
Description
Based on patients, who are treated in the University Cancer Center Hamburg (UCCH) and its contracted partner network, which comprises all cancer treating departments at the University Medical Center of Hamburg-Eppendorf (UKE), as well as 19 office-based oncologists and 20 surrounding hospitals, recruitment for the study will be done as follows:
(i) as a cancer patient during regular aftercare appointments who reports a current or past COVID-19 infection.
(ii) as an acute COVID-19 patient who reports a prevalent cancer diagnosis
Data will be collected as available from routine clinical care and includes demographic and biometric data, medical history, baseline data at inclusion as well as inpatient and intensive care unit admissions. Upon consent, patients will provide peripheral blood samples at time of inclusion and after 6 month. Recruitment is limited to a one-year period (April 2020 - April 2021).
Details
| Condition | Cancer, COVID |
|---|---|
| Age | 18years - 100years |
| Treatment | No intervention |
| Clinical Study Identifier | NCT04408339 |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Last Modified on | 19 February 2024 |
How to participate?
,
Select a site
Enter your location to find study centers near you
1 study centers available
You have selected
University Hospital Hamburg Eppendorf
Hamburg Germany
Send a message
Enter your contact details to connect with study team
Katja Weisel, MD
Primary Contact
University Hospital Hamburg Eppendorf
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.